Research at the University of Strathclyde engages with organic chemistry, medicinal chemistry, chemical biology, pharmaceutical sciences and many biological sciences. Professor Suckling and his colleagues there are currently investigating anti-infective compounds to treat bacterial and parasitic infections in humans and animals; the most advanced compound has successfully completed a phase 1 clinical trial for treating Clostridium difficile infections, while several others have achieved proof-of-concept, in particular for treating African animal trypanosomiasis.
Compounds to treat inflammatory disease are similarly effective in models of arthritis, asthma, lupus and lung fibrosis, for example. When cancer is added to this list you have a good idea of the potential impact of what we are doing. This new ebook follows various approaches to research and how to choose the correct approach for a specific disease.